AU5289193A - New influenza virus peptides, diagnostics and vaccines - Google Patents

New influenza virus peptides, diagnostics and vaccines

Info

Publication number
AU5289193A
AU5289193A AU52891/93A AU5289193A AU5289193A AU 5289193 A AU5289193 A AU 5289193A AU 52891/93 A AU52891/93 A AU 52891/93A AU 5289193 A AU5289193 A AU 5289193A AU 5289193 A AU5289193 A AU 5289193A
Authority
AU
Australia
Prior art keywords
vaccines
diagnostics
influenza virus
new influenza
virus peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52891/93A
Inventor
Jonas Blomberg
Elena Isaeva
Rudiger Pipkorn
Sergei Viazov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replico Medical AB
Original Assignee
Replico Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical AB filed Critical Replico Medical AB
Publication of AU5289193A publication Critical patent/AU5289193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU52891/93A 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines Abandoned AU5289193A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9202968 1992-10-09
SE9202968A SE9202968L (en) 1992-10-09 1992-10-09 New peptides, diagnostic antigens, their use, vaccines and drugs
PCT/SE1993/000818 WO1994009035A1 (en) 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines

Publications (1)

Publication Number Publication Date
AU5289193A true AU5289193A (en) 1994-05-09

Family

ID=20387437

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52891/93A Abandoned AU5289193A (en) 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines

Country Status (3)

Country Link
AU (1) AU5289193A (en)
SE (1) SE9202968L (en)
WO (1) WO1994009035A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843158A1 (en) * 2006-04-05 2007-10-10 Micronas Holding GmbH Pathogen detection system
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
EP2772267B1 (en) 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP3020832A1 (en) 2007-10-01 2016-05-18 Longhorn Vaccines and Diagnostics, LLC Biological specimen collection and transport system and methods of use
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2863083C (en) 2012-01-26 2023-09-19 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
CA2985652C (en) 2015-05-14 2020-03-10 Gerald W. FISHER Rapid methods for the extraction of nucleic acids from biological samples
BR112020023354A2 (en) * 2018-05-18 2021-02-09 Emergex Vaccines Holding Limited reverse peptide vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981782A (en) * 1987-05-14 1991-01-01 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
WO1994009035A1 (en) 1994-04-28
SE9202968D0 (en) 1992-10-09
SE9202968L (en) 1994-04-10

Similar Documents

Publication Publication Date Title
AU1308495A (en) Influenza vaccine
EP0621339A3 (en) Immunogenic human influenza a virus haemagglutinin polypeptides.
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
AU6304996A (en) Vaccines against hepatitis c
AU6979387A (en) Fusion protein comprising influenza virus haemagglutinin and antigenic epitope
AU4653989A (en) Biologically competent, virus inactivated albumin
AU4878096A (en) Hepatitis b vaccine
AU2741295A (en) Method for preparing an influenza virus, antigens obtained and applications thereof
AU3448797A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
AU6982096A (en) Parainfluenza virus glycoproteins and vaccines
AU8688891A (en) Chicken anemia virus vaccine and diagnostic
AU5289193A (en) New influenza virus peptides, diagnostics and vaccines
AU8684991A (en) Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives
AU5679394A (en) Hepatitis b virus vaccines
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
AU6163590A (en) Mutant pseudorabies virus, and vaccines containing the same
AU5836390A (en) Human lymphoma-associated virus
AU2961195A (en) Chicken infectious anemia virus vaccine
AU3552797A (en) Vaccine preparations
AU1194997A (en) Plasmid vaccine against pseudorabies virus
AU2946395A (en) Recombinant infectious laryngotracheitis virus and vaccine
AU5851296A (en) Malaria peptides and vaccines